Flavio Nobili Selected Research

ioflupane

1/2020	123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies.
1/2020	Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies.
1/2017	Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework.
1/2010	Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Flavio Nobili Research Topics

Disease

49	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2002
39	Dementia (Dementias) 01/2022 - 11/2005
38	Cognitive Dysfunction 01/2022 - 08/2007
20	Parkinson Disease (Parkinson's Disease) 04/2022 - 01/2010
8	Atrophy 01/2019 - 11/2005
6	REM Sleep Behavior Disorder 01/2022 - 09/2015
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2015
4	Synucleinopathies 11/2022 - 09/2015
4	Disease Progression 01/2021 - 12/2013
4	Amyloidosis 01/2019 - 01/2011
4	Parkinsonian Disorders (Parkinsonism) 01/2018 - 01/2013
3	Prodromal Symptoms 11/2022 - 01/2019
3	COVID-19 01/2022 - 01/2021
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2020 - 09/2014
2	Lewy Body Disease (Lewy Body Dementia) 01/2020 - 02/2012
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 02/2009
2	Frontotemporal Dementia (Semantic Dementia) 01/2016 - 01/2015
2	Essential Tremor (Essential Tremors) 06/2015 - 01/2010
2	Obesity 08/2014 - 01/2013
2	Stroke (Strokes) 08/2002 - 08/2002
2	Communication Disorders (Communication Disorder) 08/2002 - 08/2002
1	Anosmia 01/2022
1	Sporadic Creutzfeldt-Jakob Disease 01/2021
1	Corticobasal Degeneration 01/2021
1	Mixed Dementias 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Constipation 01/2021
1	Delirium 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021
1	Hyperglycemia 10/2020
1	Epilepsy (Aura) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	Carotid Artery Diseases 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Tauopathies 11/2019
1	Multiple Sclerosis 01/2019
1	Starvation 06/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2018
1	Heart Diseases (Heart Disease) 09/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2016
1	Brain Neoplasms (Brain Tumor) 09/2015
1	Glioma (Gliomas) 09/2015
1	2 Progressive Supranuclear Palsy 01/2015

Drug/Important Bio-Agent (IBA)

47	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2010
20	Amyloid (Amyloid Fibrils)IBA 01/2022 - 11/2011
10	Pharmaceutical PreparationsIBA 04/2022 - 01/2010
9	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2022 - 06/2012
8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 04/2012
7	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2021 - 01/2010
6	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 01/2015
6	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2008 - 01/2002
5	Cholinergic Agents (Cholinergics)IBA 01/2020 - 07/2006
4	Apolipoproteins E (ApoE)IBA 01/2022 - 03/2013
4	ioflupaneIBA 01/2020 - 01/2010
4	Biological ProductsIBA 01/2019 - 11/2005
4	Donepezil (Aricept)FDA LinkGeneric 07/2006 - 01/2002
3	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 01/2013
3	Radioisotopes (Radionuclides)IBA 10/2018 - 11/2011
3	Pemetrexed (MTA)FDA Link 02/2015 - 08/2007
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 01/2013
2	alpha-SynucleinIBA 01/2021 - 09/2015
2	Selegiline (E250)FDA LinkGeneric 01/2021 - 02/2016
2	3-Iodobenzylguanidine (Iobenguane)IBA 09/2016 - 05/2010
2	Dihydroxyphenylalanine (Dopa)IBA 09/2015 - 01/2015
2	Technetium Tc 99m Exametazime (Ceretec)FDA Link 09/2008 - 07/2003
2	OximesIBA 07/2004 - 08/2002
1	tau Proteins (tau Protein)IBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	SynucleinsIBA 01/2021
1	SteroidsIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	ElementsIBA 01/2020
1	AdiponectinIBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020
1	Levodopa (L Dopa)FDA LinkGeneric 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	nilvadipine (Escor)IBA 01/2018
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2018
1	ApolipoproteinsIBA 01/2018
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	LigandsIBA 01/2017
1	Tumor Biomarkers (Tumor Markers)IBA 01/2017
1	Antipsychotic Agents (Antipsychotics)IBA 02/2016
1	rasagiline (Azilect)FDA Link 02/2016
1	agomelatine (S20098)IBA 01/2016
1	Antidepressive Agents (Antidepressants)IBA 09/2015
1	EnzymesIBA 09/2015
1	ImmunosorbentsIBA 09/2015
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 09/2015
1	fluorodopa F 18IBA 06/2015

Therapy/Procedure

5	Therapeutics 09/2020 - 08/2002
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Precision Medicine 11/2019